Avid Bioservices Inc (CDMO)

[eastcoastguy]

The stock was Dendreon,DNDN, the first bio to commercialize a prostate immunotherapy. It was a bear attack that lasted 15 minutes and took the stock from around 24 down to 11. Stops were hit and investors wiped out. DNDN had a strong retail stockholder base and was expecting positive news from the FDA.

I own stock in both DNDN and our very own PPHM. To me DNDN is an early version of PPHM in that it was pioneering an immunotherapy drug, supported by retail, wanted to go it alone, and disdain from WS. Dendreon decided to go it alone, sold a convertible offering and raised 600M. Unfortunately, they fumbled the commercial launch of Provenge by overbuilding their manufacturing sites, poor marketing strategy and largesse at the top. Stock went from 2's to 50's and then back to the 2's. I've bought in the single digits because the platform is effective and if management gets it together they'll survive or get bought out.

With PPHM I don't see an imminent buyout. Between the ATM and E Series sales we have the $ to get Sunrise underway. We just wouldn't get enough of a premium from our current PPS. Agree with geo its a ramp up with all the March conferences, increase in PPS, and then possibly a collaboration/partnership announcement. PPS goes into the 6-10 range.

I wouldn't be surprised to see a bear raid to loosen some shares up. We still have a heavy retail base that doesn't want to let go...much like DNDN. Be careful!